Related Experiment Video

Updated: May 30, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

[Chronic pulmonary aspergillosis]

Seita Tsuji1, Kenji Ogawa

  • 1Department of Pulmonary Medicine, National Hospital Organization, Higashinagoya National Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 16, 2011
PubMed

Insights

Chronic pulmonary aspergillosis (CPA) affects patients with lung disease, often linked to tuberculosis. New antifungals like micafungin and voriconazole improve CPA management and outcomes.

Area of Science:

  • Mycology
  • Pulmonology
  • Infectious Diseases

Context:

  • Aspergillus species cause diverse pulmonary diseases, including invasive pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
  • Chronic pulmonary aspergillosis (CPA) commonly affects individuals with underlying lung conditions, particularly those with a history of pulmonary tuberculosis.
  • Aspergillus fumigatus is the most frequently identified species implicated in these infections.

Purpose:

  • To review the clinical manifestations, diagnostic approaches, and therapeutic strategies for chronic pulmonary aspergillosis (CPA).
  • To highlight recent advancements in understanding the pathogenic factors contributing to CPA.
  • To discuss the impact of novel antifungal agents on CPA patient outcomes.

Summary:

  • CPA is a significant pulmonary disease associated with chronic lung conditions, especially previous tuberculosis.
  • Diagnosis involves recognizing clinical features and utilizing appropriate diagnostic tools.
  • Treatment has been revolutionized by new antifungal medications, improving patient prognosis.

Impact:

  • Enhanced understanding of CPA pathogenesis.
  • Improved clinical management and patient outcomes through advanced diagnostics and therapeutics.
  • Provides a comprehensive resource for clinicians managing Aspergillus-related lung diseases.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...